http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102419247-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
filingDate 2017-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102419247-B1
titleOfInvention Phosphaplatin liquid formulation
abstract Disclosed are pharmaceutical compositions of phosphaplatin compounds, in particular buffered stable liquid formulations and methods of preparation of Pyrodark-2, which can be used for the treatment of various cancers.
priorityDate 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451360508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158053978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421005455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448851148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420327631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451157176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23221470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414064869

Total number of triples: 49.